NxStage Medical, Inc. (NASDAQ:NXTM)

CAPS Rating: 3 out of 5

A medical device company, which develops, manufactures and markets innovative systems for the treatment of end-stage renal disease and acute kidney failure.

Recs

1
Player Avatar mojo2007 (< 20) Submitted: 3/21/2008 11:34:28 PM : Underperform Start Price: $3.72 NXTM Score: -318.35

If there's one thing I've learned, it's that when a stock is at its 52 week low, it's probably going to go lower before it goes higher. Don't try to find the bottom.

Featured Broker Partners


Advertisement